Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Mar 26, 2026 8-K
10-K Mar 26, 2026 10-K
4 Feb 9, 2026 4
4 Feb 9, 2026 4
4 Feb 5, 2026 4
4 Feb 4, 2026 4
8-K Jan 30, 2026 8-K
8-K Dec 19, 2025 8-K
8-K Nov 13, 2025 8-K
10-Q Nov 13, 2025 10-Q
4 Nov 12, 2025 4
4 Sep 3, 2025 4
4 Sep 3, 2025 4
SCHEDULE 13G/A Aug 14, 2025
S-8 Aug 12, 2025 S-8
10-Q Aug 12, 2025 10-Q
8-K Aug 12, 2025 8-K
8-K Jun 18, 2025 8-K
4 Jun 16, 2025 4
4 Jun 16, 2025 4
4 Jun 16, 2025 4
4 Jun 16, 2025 4
4 Jun 16, 2025 4
4 Jun 16, 2025 4
4 Jun 16, 2025 4
← Newer Page 2 of 21 · 513 filings Older →